2,4-DISUBSTITUTED-PYRIDINE N-OXIDES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:EP1523476A2
公开(公告)日:2005-04-20
US6809109B2
申请人:——
公开号:US6809109B2
公开(公告)日:2004-10-26
[EN] 2,4-DISUBSTITUTED-PYRIDINE N-OXIDES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] 2,4-DISUBSTITUTEE-PYRIDINE N-OXYDES UTILES COMME INHIBITEURS DE LA TRANSCRIPTASE INVERSE DU VIH
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2004002410A2
公开(公告)日:2004-01-08
The present invention relates to 2,4-disubstituted pyridine-N-oxide compounds of formula (I) or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
2, 4-Disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
申请人:——
公开号:US20040019047A1
公开(公告)日:2004-01-29
The present invention relates to 2,4-disubstituted pyridine-N-oxide compounds of formula (I):
1
or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.